191 related articles for article (PubMed ID: 31906874)
1. AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer.
He J; Tsang JY; Xu X; Li J; Li M; Chao X; Xu Y; Luo R; Tse GM; Sun P
BMC Cancer; 2020 Jan; 20(1):18. PubMed ID: 31906874
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system in triple-negative breast cancer.
Li JP; Zhang XM; Zhang YS; Zheng LH; Liu YJ
Neoplasma; 2019 Sep; 66(5):810-817. PubMed ID: 31129969
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of the prognostic staging system in the 8th edition of the American Joint Committee on Cancer for triple-negative breast cancer: a SEER population-based analysis.
Liu YY; Yu TJ; Liu GY
Future Oncol; 2019 Feb; 15(4):391-400. PubMed ID: 30620221
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.
Luo SP; Wu QS; Chen H; Wang XX; Chen QX; Zhang J; Song CG
J Surg Res; 2020 Mar; 247():211-219. PubMed ID: 31706539
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
6. Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer.
Jang N; Choi JE; Kang SH; Bae YK
Virchows Arch; 2019 Feb; 474(2):193-200. PubMed ID: 30474738
[TBL] [Abstract][Full Text] [Related]
7. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
9. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making.
Lian CL; Li GQ; Zhou P; Wang J; He ZY; Wu SG
Breast; 2021 Oct; 59():117-123. PubMed ID: 34229126
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
Tang L; Ishikawa Y; Matsushita H; Jingu K
Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
Lombardi A; Vitale V; Nigri G; Olivieri C; Mastrangeli MR; Bizzaglia E; Amanti C
Breast J; 2020 Jul; 26(7):1265-1269. PubMed ID: 32180300
[TBL] [Abstract][Full Text] [Related]
14. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.
Ye J; Wang W; Xu L; Duan X; Cheng Y; Xin L; Zhang H; Zhang S; Li T; Liu Y
Chin J Cancer Res; 2017 Aug; 29(4):351-360. PubMed ID: 28947867
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
Zhou B; Xu L; Ye J; Xin L; Duan X; Liu Y
Anticancer Res; 2017 Aug; 37(8):4615-4621. PubMed ID: 28739761
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
17. Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
Kim JY; Lim JE; Jung HH; Cho SY; Cho EY; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
Breast Cancer Res Treat; 2018 Oct; 171(3):737-745. PubMed ID: 29931426
[TBL] [Abstract][Full Text] [Related]
18. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
Cates JMM
J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
[No Abstract] [Full Text] [Related]
19. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
Xu L; Li JH; Ye JM; Duan XN; Cheng YJ; Xin L; Liu Q; Zhou B; Liu YH
Chin Med J (Engl); 2017 Aug; 130(16):1945-1952. PubMed ID: 28776547
[TBL] [Abstract][Full Text] [Related]
20. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Feb; 168(1):269-275. PubMed ID: 29143220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]